<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37702769</PMID><DateCompleted><Year>2023</Year><Month>11</Month><Day>13</Day></DateCompleted><DateRevised><Year>2024</Year><Month>04</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1076</ISSN><JournalIssue CitedMedium="Internet"><Volume>182</Volume><Issue>11</Issue><PubDate><Year>2023</Year><Month>Nov</Month></PubDate></JournalIssue><Title>European journal of pediatrics</Title><ISOAbbreviation>Eur J Pediatr</ISOAbbreviation></Journal><ArticleTitle>Susceptibility of SARS-CoV2 infection in children.</ArticleTitle><Pagination><StartPage>4851</StartPage><EndPage>4857</EndPage><MedlinePgn>4851-4857</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00431-023-05184-w</ELocationID><Abstract><AbstractText>Coronavirus disease 2019 in children presents with distinct phenotype in comparison to adults. Overall, the pediatric infection with a generally milder clinical course of the acute infection compared to adults still faces several unknown aspects. Specifically, the presence of a wide range of inflammatory manifestations, including multisystem inflammatory syndrome in children (MIS-C), myocarditis, and long COVID in the period after infection suggests a particular susceptibility of some children upon severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Albeit peculiar complications such as long covid are less frequent in children compared to adults, research on the relationship between inflammatory syndromes and SARS-CoV-2 is rapidly evolving. &#xa0; &#xa0; Conclusions: new studies and findings continue to emerge, providing further insights into the underlying mechanisms and potential therapeutic strategies. In the present work, we revised current knowledge of the main factors accounting for such variability upon SARS-CoV-2 infection over the pediatric age group. What is Known: &#x2022; COVID19 in children overall showed a milder course compared to adults during the acute phase of the infection. &#x2022; Children showed to be susceptible to a wide range of post infectious complications including multisystem inflammatory syndrome in children (MIS-C), myocarditis, neuroinflammation, and long COVID. What is New: &#x2022; Mechanisms underlying susceptibility to a severe course of the infection were recently shown to pertain to the host. &#x2022; A specific combination of HLA was recently shown to be associated to higher susceptibility to MIS-C in children.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cotugno</LastName><ForeName>Nicola</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Clinical Immunology and Vaccinology Unit, Bambino Ges&#xf9; Children's Hospital, IRCCS, 00165, Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Chair of Pediatrics, Department of Systems Medicine, University of Rome "Tor Vergata", Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amodio</LastName><ForeName>Donato</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Clinical Immunology and Vaccinology Unit, Bambino Ges&#xf9; Children's Hospital, IRCCS, 00165, Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Chair of Pediatrics, Department of Systems Medicine, University of Rome "Tor Vergata", Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buonsenso</LastName><ForeName>Danilo</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro di Salute Globale, Universit&#xe0; Cattolica del Sacro Cuore, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Palma</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Clinical Immunology and Vaccinology Unit, Bambino Ges&#xf9; Children's Hospital, IRCCS, 00165, Rome, Italy. paolo.palma@uniroma2.it.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Chair of Pediatrics, Department of Systems Medicine, University of Rome "Tor Vergata", Rome, Italy. paolo.palma@uniroma2.it.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>PRIN: 2022ZCLC3X</GrantID><Agency>Ministero dell'Universit&#xe0; e della Ricerca</Agency><Country/></Grant><Grant><GrantID>5x1000</GrantID><Agency>Ministero della Salute</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Eur J Pediatr</MedlineTA><NlmUniqueID>7603873</NlmUniqueID><ISSNLinking>0340-6199</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C000705967">pediatric multisystem inflammatory disease, COVID-19 related</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012367" MajorTopicYN="N">RNA, Viral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009205" MajorTopicYN="Y">Myocarditis</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19 genetic susceptibility</Keyword><Keyword MajorTopicYN="N">COVID-19 vaccines</Keyword><Keyword MajorTopicYN="N">Long-COVID</Keyword><Keyword MajorTopicYN="N">MIS-C</Keyword><Keyword MajorTopicYN="N">Pediatric COVID-19</Keyword></KeywordList><CoiStatement>DB received funding from Roche and Pfizer to investigate long covid. No other conflict of interest to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>7</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>8</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>11</Month><Day>13</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>13</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>13</Day><Hour>11</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>9</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37702769</ArticleId><ArticleId IdType="pmc">PMC10640404</ArticleId><ArticleId IdType="doi">10.1007/s00431-023-05184-w</ArticleId><ArticleId IdType="pii">10.1007/s00431-023-05184-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Merad M, Blish CA, Sallusto F, Iwasaki A. The immunology and immunopathology of COVID-19. Science. 2022;375(6585):1122&#x2013;1127. doi: 10.1126/science.abm8108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abm8108</ArticleId><ArticleId IdType="pubmed">35271343</ArticleId></ArticleIdList></Reference><Reference><Citation>Pierce CA, Preston-Hurlburt P, Dai Y, Aschner CB, Cheshenko N, Galen B et al (2020) Immune responses to SARS-CoV-2 infection in hospitalized pediatric and adult patients. Sci Transl Med 12(564):eabd5487</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7658796</ArticleId><ArticleId IdType="pubmed">32958614</ArticleId></ArticleIdList></Reference><Reference><Citation>Amodio D, Cotugno N, Palma P. COVID-19 in children: from afterthought to unknown. Cell Rep Med. 2022;3(3):100558. doi: 10.1016/j.xcrm.2022.100558.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2022.100558</ArticleId><ArticleId IdType="pmc">PMC8922527</ArticleId><ArticleId IdType="pubmed">35474747</ArticleId></ArticleIdList></Reference><Reference><Citation>Pierce CA, Sy S, Galen B, Goldstein DY, Orner E, Keller MJ et al (2021) Natural mucosal barriers and COVID-19 in children. JCI Insight 6(9):e148694, 148694</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8262299</ArticleId><ArticleId IdType="pubmed">33822777</ArticleId></ArticleIdList></Reference><Reference><Citation>Brodin P. Immune determinants of COVID-19 disease presentation and severity. Nat Med. 2021;27(1):28&#x2013;33. doi: 10.1038/s41591-020-01202-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-01202-8</ArticleId><ArticleId IdType="pubmed">33442016</ArticleId></ArticleIdList></Reference><Reference><Citation>Cotugno N, Ruggiero A, Pascucci GR, Bonfante F, Petrara MR, Pighi C et al (2021) Virological and immunological features of SARS&#x2010;COV&#x2010;2 infected children with distinct symptomatology. Riggioni C, editor. Pediatr Allergy Immunol 32(8):1833&#x2013;42</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8420243</ArticleId><ArticleId IdType="pubmed">34174102</ArticleId></ArticleIdList></Reference><Reference><Citation>Cotugno N, Ruggiero A, Bonfante F, Petrara MR, Zicari S, Pascucci GR, et al. Virological and immunological features of SARS-CoV-2-infected children who develop neutralizing antibodies. Cell Rep. 2021;34(11):108852. doi: 10.1016/j.celrep.2021.108852.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.108852</ArticleId><ArticleId IdType="pmc">PMC7962998</ArticleId><ArticleId IdType="pubmed">33730580</ArticleId></ArticleIdList></Reference><Reference><Citation>Augusto DG, Murdolo LD, Chatzileontiadou DSM, Sabatino JJ, Yusufali T, Peyser ND et al (2023) A common allele of HLA is associated with asymptomatic SARS-CoV-2 infection. Nature [cited 2023 Jul 21]. Available from: https://www.nature.com/articles/s41586-023-06331-x</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10396966</ArticleId><ArticleId IdType="pubmed">37468623</ArticleId></ArticleIdList></Reference><Reference><Citation>Romani L, Del Chierico F, Macari G, Pane S, Ristori MV, Guarrasi V, et al. The Relationship between pediatric gut microbiota and SARS-CoV-2 infection. Front Cell Infect Microbiol. 2022;12:908492. doi: 10.3389/fcimb.2022.908492.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.908492</ArticleId><ArticleId IdType="pmc">PMC9304937</ArticleId><ArticleId IdType="pubmed">35873161</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanderbeck A, Maillard I. Notch signaling at the crossroads of innate and adaptive immunity. J Leukoc Biol. 2021;109(3):535&#x2013;548. doi: 10.1002/JLB.1RI0520-138R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/JLB.1RI0520-138R</ArticleId><ArticleId IdType="pubmed">32557824</ArticleId></ArticleIdList></Reference><Reference><Citation>Benamar M, Chen Q, Chou J, Jul&#xe9; AM, Boudra R, Contini P, et al. The Notch1/CD22 signaling axis disrupts Treg function in SARS-CoV-2-associated multisystem inflammatory syndrome in children. J Clin Invest. 2023;133(1):e163235. doi: 10.1172/JCI163235.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI163235</ArticleId><ArticleId IdType="pmc">PMC9797337</ArticleId><ArticleId IdType="pubmed">36282598</ArticleId></ArticleIdList></Reference><Reference><Citation>Yonker LM, Gilboa T, Ogata AF, Senussi Y, Lazarovits R, Boribong BP et al (2021) Multisystem inflammatory syndrome in children is driven by zonulin-dependent loss of gut mucosal barrier. J Clin Invest 131(14):e149633, 149633</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8279585</ArticleId><ArticleId IdType="pubmed">34032635</ArticleId></ArticleIdList></Reference><Reference><Citation>Channon-Wells S, Vito O, McArdle AJ, Seaby EG, Patel H, Shah P, et al. Immunoglobulin, glucocorticoid, or combination therapy for multisystem inflammatory syndrome in children: a propensity-weighted cohort study. Lancet Rheumatol. 2023;5(4):e184&#x2013;e199. doi: 10.1016/S2665-9913(23)00029-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2665-9913(23)00029-2</ArticleId><ArticleId IdType="pmc">PMC9949883</ArticleId><ArticleId IdType="pubmed">36855438</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar R, Rivkin MJ, Raffini L. Thrombotic complications in children with Coronavirus disease 2019 and Multisystem Inflammatory Syndrome of Childhood. J Thromb Haemost JTH. 2023;S1538&#x2013;7836(23):00434&#x2013;438.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10232718</ArticleId><ArticleId IdType="pubmed">37268064</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitworth H, Sartain SE, Kumar R, Armstrong K, Ballester L, Betensky M, et al. Rate of thrombosis in children and adolescents hospitalized with COVID-19 or MIS-C. Blood. 2021;138(2):190&#x2013;198. doi: 10.1182/blood.2020010218.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2020010218</ArticleId><ArticleId IdType="pmc">PMC8079262</ArticleId><ArticleId IdType="pubmed">33895804</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimmermann P, Curtis N. Why is COVID-19 less severe in children? A review of the proposed mechanisms underlying the age-related difference in severity of SARS-CoV-2 infections. Arch Dis Child. 2021;106(5):429&#x2013;439. doi: 10.1136/archdischild-2020-320338.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/archdischild-2020-320338</ArticleId><ArticleId IdType="pubmed">33262177</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Gennaro L, Valentini P, Sorrentino S, Ferretti MA, De Candia E, Basso M, et al. Extended coagulation profile of children with long covid: a prospective study. Sci Rep. 2022;12(1):18392. doi: 10.1038/s41598-022-23168-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-23168-y</ArticleId><ArticleId IdType="pmc">PMC9626616</ArticleId><ArticleId IdType="pubmed">36319840</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanderheiden A, Klein RS. Neuroinflammation and COVID-19. Curr Opin Neurobiol. 2022;76:102608. doi: 10.1016/j.conb.2022.102608.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.conb.2022.102608</ArticleId><ArticleId IdType="pmc">PMC9239981</ArticleId><ArticleId IdType="pubmed">35863101</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown RL, Benjamin L, Lunn MP, Bharucha T, Zandi MS, Hoskote C, et al. Pathophysiology, diagnosis, and management of neuroinflammation in COVID-19. BMJ. 2023;18(382):e073923. doi: 10.1136/bmj-2022-073923.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2022-073923</ArticleId><ArticleId IdType="pubmed">37595965</ArticleId></ArticleIdList></Reference><Reference><Citation>Hauptman AJ, Ferrafiat V. Neuroinflammatory syndromes in children. Curr Opin Psychiatry. 2023;36(2):87&#x2013;95. doi: 10.1097/YCO.0000000000000846.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/YCO.0000000000000846</ArticleId><ArticleId IdType="pubmed">36705007</ArticleId></ArticleIdList></Reference><Reference><Citation>Aubart M, Roux CJ, Durrleman C, Gins C, Hully M, Kossorotoff M, et al. Neuroinflammatory disease following severe acute respiratory syndrome coronavirus 2 infection in children. J Pediatr. 2022;247:22&#x2013;28.e2. doi: 10.1016/j.jpeds.2022.05.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpeds.2022.05.018</ArticleId><ArticleId IdType="pmc">PMC9106400</ArticleId><ArticleId IdType="pubmed">35577119</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Ayuzo Del Valle NC, Perelman C, Sepulveda R, Rebolledo PA, et al. Long-COVID in children and adolescents: a systematic review and meta-analyses. Sci Rep. 2022;12(1):9950. doi: 10.1038/s41598-022-13495-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-13495-5</ArticleId><ArticleId IdType="pmc">PMC9226045</ArticleId><ArticleId IdType="pubmed">35739136</ArticleId></ArticleIdList></Reference><Reference><Citation>Bygdell M, Kindblom JM, Martikainen J, Li H, Nyberg F. Incidence and characteristics in children with post&#x2013;COVID-19 condition in Sweden. JAMA Netw Open. 2023;6(7):e2324246. doi: 10.1001/jamanetworkopen.2023.24246.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2023.24246</ArticleId><ArticleId IdType="pmc">PMC10357335</ArticleId><ArticleId IdType="pubmed">37466944</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21(3):133&#x2013;146. doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrone D, Mateo-Urdiales A, Sacco C, Riccardo F, Bella A, Ambrosio L, et al. Reduction of the risk of severe COVID-19 due to Omicron compared to Delta variant in Italy (November 2021 - February 2022) Int J Infect Dis IJID Off Publ Int Soc Infect Dis. 2023;129:135&#x2013;141.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9877142</ArticleId><ArticleId IdType="pubmed">36708869</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D, Perramon A, Catal&#xe0; M, Torres JP, Camacho-Moreno G, Rojas-Solano M, et al. Multisystem inflammatory syndrome in children in Western countries? Decreasing incidence as the pandemic progresses?: An observational multicenter international cross-sectional study. Pediatr Infect Dis J. 2022;41(12):989&#x2013;993. doi: 10.1097/INF.0000000000003713.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000003713</ArticleId><ArticleId IdType="pmc">PMC9645445</ArticleId><ArticleId IdType="pubmed">36102705</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D, Morello R, Mariani F, De Rose C, Mastrantoni L, Zampino G et al (2023) Risk of long Covid in children infected with Omicron or pre-Omicron SARS-CoV-2 variants. Acta Paediatr Oslo Nor 1992 112(6):1284&#x2013;6</Citation><ArticleIdList><ArticleId IdType="pubmed">36938946</ArticleId></ArticleIdList></Reference><Reference><Citation>Morello R, Mariani F, Mastrantoni L, De Rose C, Zampino G, Munblit D et al (2023) Risk factors for post-COVID-19 condition (Long Covid) in children: a prospective cohort study. eClinicalMedicine 59:101961</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10101848</ArticleId><ArticleId IdType="pubmed">37073325</ArticleId></ArticleIdList></Reference><Reference><Citation>Lokanuwatsatien T, Satdhabudha A, Tangsathapornpong A, Bunjoungmanee P, Sinlapamongkolkul P, Chaiyakulsil C, et al. Prevalence and associating factors of long COVID in pediatric patients during the Delta and the Omicron variants. Front Pediatr. 2023;24(11):1127582. doi: 10.3389/fped.2023.1127582.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2023.1127582</ArticleId><ArticleId IdType="pmc">PMC10244785</ArticleId><ArticleId IdType="pubmed">37292374</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D, Martino L, Morello R, Mariani F, Fearnley K, Valentini P. Viral persistence in children infected with SARS-CoV-2: current evidence and future research strategies. Lancet Microbe. 2023;S2666&#x2013;5247(23):00115&#x2013;125.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10292824</ArticleId><ArticleId IdType="pubmed">37385286</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D, Valentini P, De Rose C, Tredicine M, PereyraBoza MDC, Camponeschi C, et al. Recovering or persisting: the immunopathological features of SARS-CoV-2 infection in children. J Clin Med. 2022;11(15):4363. doi: 10.3390/jcm11154363.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11154363</ArticleId><ArticleId IdType="pmc">PMC9369242</ArticleId><ArticleId IdType="pubmed">35955979</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D, Di Gennaro L, De Rose C, Morello R, D&#x2019;Ilario F, Zampino G, et al. Long-term outcomes of pediatric infections: from traditional infectious diseases to long Covid. Future Microbiol. 2022;17:551&#x2013;571. doi: 10.2217/fmb-2022-0031.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/fmb-2022-0031</ArticleId><ArticleId IdType="pmc">PMC8910780</ArticleId><ArticleId IdType="pubmed">35264003</ArticleId></ArticleIdList></Reference><Reference><Citation>Heiss R, Tan L, Schmidt S, Regensburger AP, Ewert F, Mammadova D, et al. Pulmonary dysfunction after pediatric COVID-19. Radiology. 2023;306(3):e221250. doi: 10.1148/radiol.221250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.221250</ArticleId><ArticleId IdType="pmc">PMC9513839</ArticleId><ArticleId IdType="pubmed">36125379</ArticleId></ArticleIdList></Reference><Reference><Citation>Pizzuto DA, Buonsenso D, Morello R, De Rose C, Valentini P, Fragano A, et al. Lung perfusion assessment in children with long-COVID: a pilot study. Pediatr Pulmonol. 2023;58(7):2059&#x2013;2067. doi: 10.1002/ppul.26432.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ppul.26432</ArticleId><ArticleId IdType="pubmed">37097045</ArticleId></ArticleIdList></Reference><Reference><Citation>Cocciolillo F, Di Giuda D, Morello R, De Rose C, Valentini P, Buonsenso D. Orbito-frontal cortex hypometabolism in children with post-COVID condition (long COVID): a preliminary experience. Pediatr Infect Dis J. 2022;41(8):663&#x2013;665. doi: 10.1097/INF.0000000000003578.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000003578</ArticleId><ArticleId IdType="pmc">PMC9281418</ArticleId><ArticleId IdType="pubmed">35839175</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao P, Liu J, Liu M. Effect of COVID-19 vaccines on reducing the risk of long COVID in the real world: a systematic review and meta-analysis. Int J Environ Res Public Health. 2022;19(19):12422. doi: 10.3390/ijerph191912422.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph191912422</ArticleId><ArticleId IdType="pmc">PMC9566528</ArticleId><ArticleId IdType="pubmed">36231717</ArticleId></ArticleIdList></Reference><Reference><Citation>Messiah SE, Hao T, DeSantis SM, Swartz MD, Talebi Y, Kohl HW, et al. Comparison of persistent symptoms following SARS-CoV-2 infection by antibody status in nonhospitalized children and adolescents. Pediatr Infect Dis J. 2022;41(10):e409&#x2013;e417. doi: 10.1097/INF.0000000000003653.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000003653</ArticleId><ArticleId IdType="pubmed">35939608</ArticleId></ArticleIdList></Reference><Reference><Citation>Parcha V, Booker KS, Kalra R, Kuranz S, Berra L, Arora G, et al. A retrospective cohort study of 12,306 pediatric COVID-19 patients in the United States. Sci Rep. 2021;11(1):10231. doi: 10.1038/s41598-021-89553-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-89553-1</ArticleId><ArticleId IdType="pmc">PMC8119690</ArticleId><ArticleId IdType="pubmed">33986390</ArticleId></ArticleIdList></Reference><Reference><Citation>Milani GP, Buonsenso D, Marchisio P, Agostoni C, Corso CM, Guarino A et al (2023) Gastroenteritis is less severe but is more often associated with systemic inflammation in SARS-CoV-2-positive than in SARS-CoV-2-negative children. Pediatr Infect Dis J</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10417221</ArticleId><ArticleId IdType="pubmed">37314203</ArticleId></ArticleIdList></Reference><Reference><Citation>Puoti MG, Rybak A, Kiparissi F, Gaynor E, Borrelli O. SARS-CoV-2 and the gastrointestinal tract in children. Front Pediatr. 2021;9:617980. doi: 10.3389/fped.2021.617980.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2021.617980</ArticleId><ArticleId IdType="pmc">PMC7937901</ArticleId><ArticleId IdType="pubmed">33692973</ArticleId></ArticleIdList></Reference><Reference><Citation>Pegoraro F, Trapani S, Indolfi G. Gastrointestinal, hepatic and pancreatic manifestations of COVID-19 in children. Clin Res Hepatol Gastroenterol. 2022;46(4):101818. doi: 10.1016/j.clinre.2021.101818.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinre.2021.101818</ArticleId><ArticleId IdType="pmc">PMC8486685</ArticleId><ArticleId IdType="pubmed">34607068</ArticleId></ArticleIdList></Reference><Reference><Citation>Abbasi J. COVID-19 and mRNA vaccines-first large test for a new approach. JAMA. 2020;324(12):1125&#x2013;1127. doi: 10.1001/jama.2020.16866.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.16866</ArticleId><ArticleId IdType="pubmed">32880613</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiolet T, Kherabi Y, MacDonald CJ, Ghosn J, Peiffer-Smadja N. Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis. 2022;28(2):202&#x2013;221.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8548286</ArticleId><ArticleId IdType="pubmed">34715347</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC COVID-19 Response Team, Food and Drug Administration (2021) Allergic reactions including anaphylaxis after receipt of the first dose of Pfizer-BioNTech COVID-19 vaccine - United States, December 14&#x2013;23, 2020. MMWR Morb Mortal Wkly Rep 70(2):46&#x2013;51</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7808711</ArticleId><ArticleId IdType="pubmed">33444297</ArticleId></ArticleIdList></Reference><Reference><Citation>Patone M, Mei XW, Handunnetthi L, Dixon S, Zaccardi F, Shankar-Hari M, et al. Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection. Nat Med. 2022;28(2):410&#x2013;422. doi: 10.1038/s41591-021-01630-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01630-0</ArticleId><ArticleId IdType="pmc">PMC8863574</ArticleId><ArticleId IdType="pubmed">34907393</ArticleId></ArticleIdList></Reference><Reference><Citation>Kracalik I, Oster ME, Broder KR, Cortese MM, Glover M, Shields K, et al. Outcomes at least 90 days since onset of myocarditis after mRNA COVID-19 vaccination in adolescents and young adults in the USA: a follow-up surveillance study. Lancet Child Adolesc Health. 2022;6(11):788&#x2013;798. doi: 10.1016/S2352-4642(22)00244-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(22)00244-9</ArticleId><ArticleId IdType="pmc">PMC9555956</ArticleId><ArticleId IdType="pubmed">36152650</ArticleId></ArticleIdList></Reference><Reference><Citation>Isaak A, Bischoff LM, Faron A, Endler C, Mesropyan N, Sprinkart AM, et al. Multiparametric cardiac magnetic resonance imaging in pediatric and adolescent patients with acute myocarditis. Pediatr Radiol. 2021;51(13):2470&#x2013;2480. doi: 10.1007/s00247-021-05169-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00247-021-05169-7</ArticleId><ArticleId IdType="pmc">PMC8599260</ArticleId><ArticleId IdType="pubmed">34435226</ArticleId></ArticleIdList></Reference><Reference><Citation>Manno EC, Amodio D, Cotugno N, Rossetti C, Giancotta C, Santilli V, et al. Higher troponin levels on admission are associated with persistent cardiac magnetic resonance lesions in children developing myocarditis after mRNA-based COVID-19 vaccination. Pediatr Infect Dis J. 2023;42(2):166&#x2013;171. doi: 10.1097/INF.0000000000003762.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000003762</ArticleId><ArticleId IdType="pmc">PMC9838608</ArticleId><ArticleId IdType="pubmed">36638405</ArticleId></ArticleIdList></Reference><Reference><Citation>Amodio D, Pascucci GR, Cotugno N, Rossetti C, Manno EC, Pighi C, Morrocchi E, D'Alessandro A, Perrone MA, Valentini A, Franceschini A, Chinali M, Deodati A, Azzari C, Rossi P, Cianfarani S, Andreani M, Porzio O, Palma P (2023) Similarities and differences between myocarditis following COVID-19 mRNA vaccine and multiple inflammatory syndrome with cardiac involvement in children. Clin Immunol 1:109751. 10.1016/j.clim.2023.109751. Online ahead of print. PMID: 37660743</Citation><ArticleIdList><ArticleId IdType="pubmed">37660743</ArticleId></ArticleIdList></Reference><Reference><Citation>Gubernot D, Jazwa A, Niu M, Baumblatt J, Gee J, Moro P et al (2021) U.S. Population-based background incidence rates of medical conditions for use in safety assessment of COVID-19 vaccines. Vaccine 39(28):3666&#x2013;77</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8118666</ArticleId><ArticleId IdType="pubmed">34088506</ArticleId></ArticleIdList></Reference><Reference><Citation>Mevorach D, Anis E, Cedar N, Bromberg M, Haas EJ, Nadir E, et al. Myocarditis after BNT162b2 mRNA vaccine against Covid-19 in Israel. N Engl J Med. 2021;385(23):2140&#x2013;2149. doi: 10.1056/NEJMoa2109730.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2109730</ArticleId><ArticleId IdType="pmc">PMC8531987</ArticleId><ArticleId IdType="pubmed">34614328</ArticleId></ArticleIdList></Reference><Reference><Citation>Witberg G, Barda N, Hoss S, Richter I, Wiessman M, Aviv Y, et al. Myocarditis after Covid-19 vaccination in a large health care organization. N Engl J Med. 2021;385(23):2132&#x2013;2139. doi: 10.1056/NEJMoa2110737.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2110737</ArticleId><ArticleId IdType="pmc">PMC8531986</ArticleId><ArticleId IdType="pubmed">34614329</ArticleId></ArticleIdList></Reference><Reference><Citation>Karlstad &#xd8;, Hovi P, Husby A, H&#xe4;rk&#xe4;nen T, Selmer RM, Pihlstr&#xf6;m N, et al. SARS-CoV-2 vaccination and myocarditis in a Nordic cohort study of 23 million residents. JAMA Cardiol. 2022;7(6):600&#x2013;612. doi: 10.1001/jamacardio.2022.0583.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2022.0583</ArticleId><ArticleId IdType="pmc">PMC9021987</ArticleId><ArticleId IdType="pubmed">35442390</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Vu S, Bertrand M, Jabagi MJ, Botton J, Drouin J, Baricault B, et al. Age and sex-specific risks of myocarditis and pericarditis following Covid-19 messenger RNA vaccines. Nat Commun. 2022;13(1):3633. doi: 10.1038/s41467-022-31401-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-31401-5</ArticleId><ArticleId IdType="pmc">PMC9233673</ArticleId><ArticleId IdType="pubmed">35752614</ArticleId></ArticleIdList></Reference><Reference><Citation>Buchan SA, Seo CY, Johnson C, Alley S, Kwong JC, Nasreen S, et al. Epidemiology of myocarditis and pericarditis following mRNA vaccination by vaccine product, schedule, and interdose interval among adolescents and adults in Ontario, Canada. JAMA Netw Open. 2022;5(6):e2218505. doi: 10.1001/jamanetworkopen.2022.18505.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.18505</ArticleId><ArticleId IdType="pmc">PMC9233237</ArticleId><ArticleId IdType="pubmed">35749115</ArticleId></ArticleIdList></Reference><Reference><Citation>Yonker LM, Swank Z, Bartsch YC, Burns MD, Kane A, Boribong BP, et al. Circulating spike protein detected in post-COVID-19 mRNA vaccine myocarditis. Circulation. 2023;147(11):867&#x2013;876. doi: 10.1161/CIRCULATIONAHA.122.061025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.122.061025</ArticleId><ArticleId IdType="pmc">PMC10010667</ArticleId><ArticleId IdType="pubmed">36597886</ArticleId></ArticleIdList></Reference><Reference><Citation>Amodio D, Manno EC, Cotugno N, Santilli V, Franceschini A, Perrone MA, et al. Relapsing myocarditis following initial recovery of post COVID-19 vaccination in two adolescent males &#x2013; Case reports. Vaccine X. 2023;14:100318. doi: 10.1016/j.jvacx.2023.100318.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvacx.2023.100318</ArticleId><ArticleId IdType="pmc">PMC10224772</ArticleId><ArticleId IdType="pubmed">37303596</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee D, Le Pen J, Yatim A, Dong B, Aquino Y, Ogishi M et al (2023) Inborn errors of OAS-RNase L in SARS-CoV-2-related multisystem inflammatory syndrome in children. Science 379(6632):eabo3627</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10451000</ArticleId><ArticleId IdType="pubmed">36538032</ArticleId></ArticleIdList></Reference><Reference><Citation>Sacco K, Castagnoli R, Vakkilainen S, Liu C, Delmonte OM, Oguz C, et al. Immunopathological signatures in multisystem inflammatory syndrome in children and pediatric COVID-19. Nat Med. 2022;28(5):1050&#x2013;1062. doi: 10.1038/s41591-022-01724-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01724-3</ArticleId><ArticleId IdType="pmc">PMC9119950</ArticleId><ArticleId IdType="pubmed">35177862</ArticleId></ArticleIdList></Reference><Reference><Citation>Zambrano LD, Wu MJ, Martin L, Malloch L, Chen S, Newhams MM, et al. Risk factors for multisystem inflammatory syndrome in children: a case-control investigation. Pediatr Infect Dis J. 2023;42(6):e190&#x2013;e196. doi: 10.1097/INF.0000000000003900.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000003900</ArticleId><ArticleId IdType="pmc">PMC10265536</ArticleId><ArticleId IdType="pubmed">37000922</ArticleId></ArticleIdList></Reference><Reference><Citation>Lammi V, Nakanishi T, Jones SE, Andrews SJ, Karjalainen J, Cort&#xe9;s B et al (2023) Genome-wide association study of long COVID [Internet]. Genetic Genomic Med [cited 2023 Jul 22]. 10.1101/2023.06.29.23292056</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>